Glycerol Kinase Deficiency (GKD), as the name suggests, is a genetic disorder, caused due to defects/deficiency in the enzyme Glycerol Kinase. The disease is characterized by acidosis, hypoglycemia, elevated blood and urine levels of glycerol, strabismus, and spasticity, along with growth and mental retardation. Two forms of the disease are recognized. The pure GKD provides quite a varied clinical picture. The condition may range from an asymptomatic state to a severe metabolic disorder. The severe form is usually exhibited in the infantile form of the disease. The complex form of the disease involves defects in the contiguous Congenital Adrenal Hyperplasia and/or Duchenne Muscular Dystrophy loci. This form of the disease therefore, presents with hypoglycemia, hyponatremia, hyperkalemia, low serum cortisol levels, and high ACTH levels.
Increased urinary and serum levels of glycerol are enough diagnostic indicators of GKD. Treatment of the disease aims at a low-fat diet and preventing fasting and/or a hypercatabolic state. However, in the case of a complex GKD, glucocorticoid replacements may be necessary.